Physician profile
Bunan Alnaif
NPI 1699736629
$139,338.65
in general payments reported to CMS, 2019-2025
58 companies · $8,140 in 2025
The $8,140 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $1,828 · 2021: $24K · 2022: $23K · 2023: $16K · 2024: $11K · 2025: $8,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $6,843 · Food and Beverage: $4,322 · Gift: $22.84 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,207.50 |
| Travel and Lodging | $6,843.36 |
| Food and Beverage | $4,321.89 |
| Gift | $22.84 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $44,967.72 | 2019-2021 | |
| Myovant Sciences INC. | $32,002.60 | 2021-2022 | |
| Astellas Pharma US INC | $26,790.06 | 2019-2025 | Veozah, Myrbetriq |
| Amag Pharmaceuticals, INC. | $5,364.10 | 2019 | |
| Coloplast Corp | $4,907.64 | 2019-2022 | |
| Axonics, INC. | $3,338.74 | 2022 | |
| Applied Medical Resources Corporation | $2,077.10 | 2024-2025 | Gelpoint V-Path |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,052.61 | 2019-2023 | Xifaxan |
| Abbvie INC. | $2,037.62 | 2019-2025 | Ubrelvy, Botox, Qulipta |
| Intuitive Surgical, INC. | $2,023.27 | 2023-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,985.23 | 2021-2025 | Altaviva, Interstim |
| Mimedx Group, INC. | $1,722.88 | 2025 | |
| Amgen INC. | $1,469.66 | 2019-2025 | Evenity, Prolia |
| Stryker Corporation | $1,194.04 | 2023-2025 | 1688, Spy-Phi System, 1788 |
| Allergan, INC. | $655.03 | 2019-2022 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bunan Alnaif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.